Dealings in securities by an associate of directors
Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis” or “the Company”)
Dealings in securities by an associate of directors
In terms of paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information,
relating to dealings in securities by associates of directors of the Company, is disclosed:
Directors: Gary Shayne and Crispian Dillon
Type of director: Both directors serve on the board of directors of
the Company as non-executive directors
Name of associate: Coast2Coast Capital (“C2C Capital”) in which
Gary Shayne and Crispian Dillon jointly hold an
indirect controlling shareholding through the
ultimate holding company, Coast2Coast
Communications Limited
Nature of transaction: On 11 May 2018 C2C Capital agreed to purchase
Ascendis shares, subject to receipt of South
African Reserve Bank approval
Date of transaction: 11 May 2018
Type of transaction: Off-market purchase of shares
Class of shares: Ordinary shares
Number of shares: 4,293,410
Price per share: R22.00
Total value of transaction: R94,455,020.00
Nature of interest: Indirect beneficial
Written clearance obtained: Clearance was obtained from the Chairman
Bryanston
11 May 2018
Sponsor
Questco Corporate Advisory Proprietary Limited
Date: 11/05/2018 09:26:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.